Builds the path from clinical innovation to real-world adoption. Focused on how healthcare reaches people, not just markets.
About
Liam operates at the intersection of healthcare, commercialization, and emerging therapeutic models. With leadership experience across multiple healthcare ventures in the UK, he brings a practitioner’s understanding of how medical innovation transitions from concept to patient impact.
His work is grounded in a critical gap most healthcare systems fail to solve, translating clinically sound solutions into scalable, accessible products. He focuses on go to market strategy, regulatory navigation, and distribution models that enable healthcare innovations to reach end users, particularly in B2C environments where trust, compliance, and usability converge.
Liam has been closely involved in building and advising healthcare companies across diagnostics, digital health, and patient-centric platforms, shaping pathways that move beyond institutional adoption into direct consumer engagement. His approach challenges traditional healthcare delivery models by prioritizing accessibility, speed to market, and real-world usability.
He is also actively engaged in frontier areas of health innovation, including cannabinoid-based therapeutics and alternative treatment ecosystems. His interest lies not just in the science, but in building commercially viable and regulated pathways for emerging therapies to enter mainstream healthcare systems.
At IAP, Liam supports health tech ventures in defining their commercialization strategy, bridging clinical validation with scalable market entry, and ensuring that innovation translates into tangible patient outcomes.
Healthcare does not scale by invention alone. It scales when it reaches people.